U-Neuron Biomedical Stock

U-Neuron Biomedical EBIT Margin

The EBIT Margin (Operating Margin) of U-Neuron Biomedical (6973.TWO) as of Aug 1, 2026 is -149.23 %. In the previous year, EBIT Margin (Operating Margin) was -334.24 % — a change of -55.35% (higher).

EBIT Margin

-149.23 %

YoY

-55.35%

Last updated:

EBIT Margin (Operating Margin) of U-Neuron Biomedical is 2026 -149.23 % . EBIT Margin (Operating Margin) of U-Neuron Biomedical was 2025 -334.24 % . It decreases by -55.35% higher compared to the previous year.

For U-Neuron Biomedical, the operating (EBIT) margin of -149.2% is down versus -53.0% a few years ago.

Access this data via the Eulerpool API

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

EBIT Margin (Operating Margin) of U-Neuron Biomedical is -149.23 % in 2026.

Access this data via the Eulerpool API

Margins — U-Neuron Biomedical

All Key Metrics — U-Neuron Biomedical